Title : Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis.

Pub. Date : 2005 Nov

PMID : 16241970

1 Functional Relationships(s)
Compound Name
Protein Name
1 In patient with NABs, measurements should be repeated, and therapy with IFN-beta should be discontinued in patients with high titres of NABs sustained at repeated measurements with 3- to 6-month intervals (Level A recommendation). nabs interferon beta 1 Homo sapiens